Healthcare Services

Global Prenatal Testing & Newborn Screening Market Expected to Reach $12.22 Billion by 2030 with 11.8% CAGR

April 6, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Prenatal Testing & Newborn Screening Market Over The Period 2026–2030?

The prenatal testing & newborn screening market size has experienced rapid expansion in recent years. It is projected to grow from $6.98 billion in 2025 to $7.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.3%. The growth observed in prior periods can be attributed to the broader reach of public health screening initiatives, an increase in institutional births, the availability of neonatal care facilities, a heightened emphasis on early disease detection, and enhancements in diagnostic testing coverage.

The prenatal testing & newborn screening market size is anticipated to undergo rapid expansion in the coming years. It is forecast to reach $12.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.8%. The projected growth in this period stems from factors such as the increasing reach of national screening mandates, the rising adoption of digital diagnostic platforms, growing investments in maternal and child healthcare, an increasing emphasis on preventive healthcare models, and the expanding utilization of AI-assisted diagnostics. Key trends expected during the forecast period include the increasing uptake of integrated prenatal and newborn screening programs, the rising application of combined screening and diagnostic technologies, the growing implementation of early intervention protocols, the expansion of automated screening workflows, and an enhanced focus on population-wide screening.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

What Underlying Factors Are Accelerating The Growth Of The Prenatal Testing & Newborn Screening Market?

A high incidence of genetic diseases in infants has been a major contributor to the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic conditions, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, in particular, affects millions globally and is highly prevalent among populations with ancestral ties to Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, a study at Rady Children’s Hospital, as reported by the US-based Rady Children’s Institute for Genomic Medicine in February 2023, indicated that single-locus (Mendelian) genetic diseases accounted for 41% of infant deaths. This widespread occurrence of genetic diseases in babies has significantly boosted the demand for the prenatal testing and newborn screening market.

Prenatal Testing & Newborn Screening Market Driver: Rising Birth Rate Fuels Growth Of Prenatal Testing And Newborn Screening Market

How Is The Prenatal Testing & Newborn Screening Market Divided Into Its Major Segments?

The prenatal testing & newborn screening market covered in this report is segmented –

1) By Diagnostic Type: Non-Invasive, Invasive

2) By Technology: Screening Technology, Diagnostic Technology

3) By End User: Hospitals, Diagnostic centers

Subsegments:

1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

What Major Market Trends Are Driving Changes In The Prenatal Testing & Newborn Screening Market?

Companies operating within the prenatal testing & newborn screening market are primarily focused on developing newborn screening devices to enhance the early detection of genetic, metabolic, and other health conditions, thereby enabling timely interventions and improved health outcomes for newborns. A newborn screening point-of-care device is engineered to deliver faster, more accessible, and cost-effective screening for newborns, accommodating the seven standard newborn screening tests conducted globally. For instance, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is designed to be low-cost, estimated to be about one-fifth the price of existing solutions, which often range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to improve access to critical health services for newborns, particularly in underserved regions.

Who Are The Prominent Organizations Shaping The Prenatal Testing & Newborn Screening Market?

Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

Read the full prenatal testing & newborn screening market report here:

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Which Region Is Projected To Dominate The Prenatal Testing & Newborn Screening Market During The Forecast Period?

North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Prenatal Testing & Newborn Screening Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

Dna Sequencing Global Market Report

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Next Generation Sequencing Market

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Protein Sequencing Global Market Report

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795